Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Pharmacology, Biochemistry, and Behavior
|
August 1, 1991
Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration
D R Britton, P Curzon, R G Mackenzie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 1997
Breast cancer patients' attitudes about rationing postlumpectomy radiation therapy: applicability of trade-off methods to policy-making
V A Palda, H A Llewellyn-Thomas, R G Mackenzie, et al.
Annals of the New York Academy of Sciences
|
June 12, 1978
Differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine on feeding in rats
B G Hoebel, F P Zemlan, M E Trulson, et al.
The Journal of Biological Chemistry
|
September 5, 1992
Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation
N J Pollock, A M Manelli, C W Hutchins, et al.
British Journal of Pharmacology
|
February 1, 1997
Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem
S R Glaum, R J Miller, H Rhim, et al.
Molecular Pharmacology
|
December 1, 1993
Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization
D E Frail, A M Manelli, D G Witte, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
April 24, 2001
Risk-adapted therapy for clinical stage I-II Hodgkin's disease: 7-years results of radiotherapy alone for low-risk disease, and ABVD and radiotherapy for high-risk disease
R G MacKenzie, E Franssen, R Wong, et al.
American Journal of Hypertension
|
June 1, 1990
A68930: a potent and specific agonist for the D-1 dopamine receptor
J W Kebabian, C Briggs, D R Britton, et al.
The Journal of Biological Chemistry
|
May 28, 1998
A point mutation in Galphao and Galphai1 blocks interaction with regulator of G protein signaling proteins
K L Lan, N A Sarvazyan, R Taussig, et al.
European Journal of Pharmacology
|
January 1, 1994
Characterization of the human dopamine D3 receptor expressed in transfected cell lines
R G MacKenzie, D VanLeeuwen, T A Pugsley, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Pharmacology, Biochemistry, and Behavior
|
August 1, 1991
Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration
D R Britton, P Curzon, R G Mackenzie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 1997
Breast cancer patients' attitudes about rationing postlumpectomy radiation therapy: applicability of trade-off methods to policy-making
V A Palda, H A Llewellyn-Thomas, R G Mackenzie, et al.
Annals of the New York Academy of Sciences
|
June 12, 1978
Differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine on feeding in rats
B G Hoebel, F P Zemlan, M E Trulson, et al.
The Journal of Biological Chemistry
|
September 5, 1992
Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation
N J Pollock, A M Manelli, C W Hutchins, et al.
British Journal of Pharmacology
|
February 1, 1997
Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem
S R Glaum, R J Miller, H Rhim, et al.
Molecular Pharmacology
|
December 1, 1993
Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization
D E Frail, A M Manelli, D G Witte, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
April 24, 2001
Risk-adapted therapy for clinical stage I-II Hodgkin's disease: 7-years results of radiotherapy alone for low-risk disease, and ABVD and radiotherapy for high-risk disease
R G MacKenzie, E Franssen, R Wong, et al.
American Journal of Hypertension
|
June 1, 1990
A68930: a potent and specific agonist for the D-1 dopamine receptor
J W Kebabian, C Briggs, D R Britton, et al.
The Journal of Biological Chemistry
|
May 28, 1998
A point mutation in Galphao and Galphai1 blocks interaction with regulator of G protein signaling proteins
K L Lan, N A Sarvazyan, R Taussig, et al.
European Journal of Pharmacology
|
January 1, 1994
Characterization of the human dopamine D3 receptor expressed in transfected cell lines
R G MacKenzie, D VanLeeuwen, T A Pugsley, et al.
Page
of 8